Title of article :
The Effects of the Synthetic Antioxidant, Tempol, on Serum Glucose and Lipid
Profile of Diabetic and Non-Diabetic Rats
Author/Authors :
Shahidi، Siamak نويسنده , , Jabbarpour، Zahra نويسنده Department of Physiology, School of Medicine, Hamadan
University of Medical Sciences, Hamadan, IR Iran , , Saidijam، Masoud نويسنده Research Center for Molecular Medicine, Hamadan University
of Medical Sciences, Hamadan, IR Iran , , Esmaeili، Rasoul نويسنده Students Research Committee, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran , , Komaki، Alireza نويسنده , , Hashemi-Firouzi، Nasrin نويسنده Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran. Hashemi-Firouzi, Nasrin
Issue Information :
دوفصلنامه با شماره پیاپی 0 سال 2016
Abstract :
Hyperlipidemia and low antioxidant levels is one the diabetes side
effects. Some studies have indicated the possible effects of nutrients
on the improvement of hyperlipidemia, by their antioxidants ingredients.
The aim of the present study was to evaluate the effect of the synthetic
antioxidant, tempol, on blood lipid profiles and glucose levels in
healthy and diabetic rats. Adult Wistar rats were randomly divided to
four experimental groups including, healthy control, diabetic control,
diabetic receiving tempol and healthy receiving tempol groups. Diabetes
was induced by injection of streptozotocin (60 mg/kg, Intraperitoneally
(IP)). The rats were then fed saline or tempol (30 mg/kg) by gavage for
60 days. Blood samples were collected by cardiac puncture. Next,
glucose, high-density lipoprotein (HDL), low-density lipoprotein (LDL),
very low-density lipoprotein (VLDL), cholesterol, triglyceride and HbA1c
were measured by specific kits. Also, the coronary risk index was
calculated. The blood glucose level increased following diabetes
induction. The level of blood glucose in the diabetic receiving tempol
group decreased compared to the control diabetic group. The comparison
of LDL, VLDL, cholesterol, triglyceride, HbA1c and coronary risk index
among experimental groups indicated the increase of these factors in the
diabetic group. High-density lipoprotein in the diabetic groups was
lower than the other groups. It can be concluded that tempol can improve
dyslipidemia and may decrease hyperglycemia in diabetes. It seems that
antioxidants such as tempol can improve dyslipidemia and may decrease
hyperglycemia in diabetes.
Journal title :
Avicenna Journal of Medical Biochemistry
Journal title :
Avicenna Journal of Medical Biochemistry